Doseloop Beta

Ibandronate

medication Under review

A bisphosphonate medication used to prevent and treat osteoporosis by slowing bone breakdown and increasing bone density.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence from clinical trials and observational studies supports ibandronate's efficacy in increasing bone mineral density and improving quality of life in postmenopausal women with osteoporosis. Long-term data confirm sustained BMD gains over five years with monthly oral or quarterly IV regimens, alongside good tolerability. However, studies are primarily in osteoporotic populations rather than healthy subjects, limiting direct applicability to healthy individuals, with meta-analyses indicating comparable fracture risk reduction to other bisphosphonates for nonvertebral fractures.

Reported Benefits

No side effects tracked yet

No side effects have been reported by studies or users for this habit yet.

Research (3 studies)

Meta-Analysis

The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies.

International Journal of Clinical Pharmacy • 2024

Not specified in available data

Cohort study

Clinical Effects of a 6-Month Treatment Course of Ibandronate, Vitamin D, and Calcium in Postmenopausal Women with Osteoporosis from Central America

International Journal of Molecular Immunology • 2013 • n=308

Not specified in available data

Systematic Review

Efficacy of ibandronate: a long term confirmation

Clinical Cases in Mineral and Bone Metabolism • 2010 • n=8710

Not specified in available data

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 1
Side effects noted 0